2012 Economic Outlook - Report Highlights OncoGenex Pharmaceuticals Inc and Pacira Pharmaceuticals Inc

Marketwired

HONG KONG--(Marketwire -04/26/12)- Today, www.BrightonMarkets.com announced new reports highlighting OncoGenex Pharmaceuticals Inc (OGXI - News) and Pacira Pharmaceuticals Inc (PCRX - News). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=OGXI&cob=PCRX.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on OncoGenex Pharmaceuticals Inc for its current position within the healthcare industry. OncoGenex Pharmaceuticals, Inc. (OncoGenex) is a biopharmaceutical company engaged in the development and commercialization of cancer therapies. As of December 31, 2010, the Company had five product candidates in its pipeline, custirsen, OGX-427, OGX-225, SN2310 and CSP-9222. Of the product candidates in its pipeline, custirsen, OGX-427 and SN2310 are clinical-stage assets. The full research report on OncoGenex Pharmaceuticals Inc (OGXI - News) is available here: www.BrightonMarkets.com/index.php?coa=OGXI.

Brighton Markets has released research on Pacira Pharmaceuticals Inc for its changing role within the healthcare industry. Pacira Pharmaceuticals, Inc. (Pacira), formerly Pacira, Inc., is the holding company for the Company's California operating subsidiary of the same name, which it refers to as PPI-California. The full research report on Pacira Pharmaceuticals Inc (PCRX - News) is available here: www.BrightonMarkets.com/index.php?cob=PCRX.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact:
View Comments (0)